|
1
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li D: The molecular epidemiologic research
of esophageal carcinoma in China. Chin J Epidemiology. 24:939–943.
2003.
|
|
3
|
Furihata T, Sakai T, Kawamata H, Omotehara
F, Shinagawa Y, Imura J, Ueda Y, Kubota K and Fujimori T: A new in
vivo model for studying invasion and metastasis of esophageal
squamous cell carcinoma. Int J Oncol. 19:903–907. 2001.PubMed/NCBI
|
|
4
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: Past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Latronico MV, Catalucci D and Condorelli
G: MicroRNA and cardiac pathologies. Physiol Genomics. 34:239–242.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feber A, Xi L, Luketich JD, Pennathur A,
Landreneau RJ, Wu M, Swanson SJ, Godfrey TE and Litle VR: MicroRNA
expression profiles of esophageal cancer. J Thorac Cardiovasc Surg.
135:255–260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo Y, Chen Z, Zhang L, Zhou F, Shi S,
Feng X, Li B, Meng X, Ma X, Luo M, et al: Distinctive microRNA
profiles relating to patient survival in esophageal squamous cell
carcinoma. Cancer Res. 68:26–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ogawa R, Ishiguro H, Kuwabara Y, Kimura M,
Mitsui A, Katada T, Harata K, Tanaka T and Fujii Y: Expression
profiling of micro-RNAs in human esophageal squamous cell carcinoma
using RT-PCR. Med Mol Morphol. 42:102–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tibshirani R, Hastie T, Narasimhan B and
Chu G: Diagnosis of multiple cancer types by shrunken centroids of
gene expression. Proc Natl Acad Sci USA. 99:6567–6572. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bass AJ and Meyerson M: Genome-wide
association study in esophageal squamous cell carcinoma.
Gastroenterology. 137:1573–1576. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang LD, Zhou FY, Li XM, Sun LD, Song X,
Jin Y, Li JM, Kong GQ, Qi H, Cui J, et al: Genome-wide association
study of esophageal squamous cell carcinoma in Chinese subjects
identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet.
42:759–763. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y,
Liu Z, Zhan Q, Liu Y, Yu D, et al: Genome-wide association study
identifies three new susceptibility loci for esophageal
squamous-cell carcinoma in Chinese populations. Nat Genet.
43:679–684. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu C, Li D, Jia W, Hu Z, Zhou Y, Yu D,
Tong T, Wang M, Lin D, Qiao Y, et al: Genome-wide association study
identifies common variants in SLC39A6 associated with length of
survival in esophageal squamous-cell carcinoma. Nat Genet.
45:632–638. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shimada H, Ochiai T and Nomura F: Japan
p53 Antibody Research Group: Titration of serum P53 antibodies in
1,085 patients with various types of malignant tumors: A
multiinstitutional analysis by the Japan P53 antibody research
group. Cancer. 97:682–689. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gomes NP and Espinosa JM: Gene-specific
repression of the p53 targer gene PUMA via intragenic CTCF-Cohesin
binding. Genes Dev. 24:1022–1034. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B,
Korzh V, Lodish HF and Lim B: Micro RNA-125b is anovel negative
regulator of p53. Genes Dev. 23:862–876. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Luthra R, Singh RR, Luthra MG, Li YX,
Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, et al:
MicroRNA-196a targets annexin A1: A microRNA-mediated mechanism of
annexin A1 downregulation in cancers. Oncogene. 27:6667–6678. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee KH, Goan YG, Hsiao M, Lee CH, Jian SH,
Lin JT, Chen YL and Lu PJ: MicroRNA-373 (miR-373)
post-transcriptionally regulates large tumor suppressor, homolog 2
(LATS2) and stimulates proliferation in human esophageal cancer.
Exp Cell Res. 315:2529–2538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kurashige J, Kamohara H, Watanabe M,
Tanaka Y, Kinoshita K, Saito S, Hiyoshi Y, Iwatsuki M, Baba Y, Baba
H, et al: Serum microRNA-21 is a novel biomarker in patients with
esophageal squamous cell carcinoma. J Surg Oncol. 106:188–192.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H
and Liu Z: MicroRNA-10b promotes migration and invasion through
KLF4 in human esophageal cancer cell lines. J Biol Chem.
285:7986–7994. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matsushima K, Isomoto H, Kohno S and Nakao
K: MicroRNAs and esophageal squamous cell carcinoma. Digestion.
82:138–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu BL, Xu LY, Du ZP, Liao LD, Zhang HF,
Huang Q, Fang GQ and Li EM: MiRNA profile in esophageal squamous
cell carcinoma: Downregulation of miR-143 and miR-145. World J
Gastroenterol. 17:79–88. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tian S, Huang S, Wu S, Guo W, Li J and He
X: MicroRNA-1285 inhibits the expression of p53 by directly
targeting its 3′ untranslated region. Biochem Biophys Res Commun.
396:435–439. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tao ZH, Wan JL, Zeng LY, Xie L, Sun HC,
Qin LX, Wang L, Zhou J, Ren ZG, Li YX, et al: miR-612 suppresses
the invasive-metastatic cascade in hepatocellular carcinoma. J Exp
Med. 210:789–803. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Landi D, Gemignani F, Naccarati A, Pardini
B, Vodicka P, Vodickova L, Novotny J, Försti A, Hemminki K, Canzian
F and Landi S: Polymorphisms within micro-RNA-binding sites and
risk of sporadic colorectal cancer. Carcinogenesis. 29:579–584.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Balaguer F, Moreira L, Lozano JJ, Link A,
Ramirez G, Shen Y, Cuatrecasas M, Arnold M, Meltzer SJ, Syngal S,
et al: Colorectal cancers with microsatellite instability display
unique miRNA profiles. Clin Cancer Res. 17:6239–6249. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim HK, Prokunina-Olsson L and Chanock SJ:
Common genetic variants in miR-1206 (8q24.2) and miR-612 (11q13.3)
affect biogenesis of mature miRNA forms. PLoS One. 10:e474542012.
View Article : Google Scholar
|
|
30
|
Tang J, Tao ZH, Wen D, Wan JL, Liu DL,
Zhang S, Cui JF, Sun HC, Wang L, Zhou J, et al: MiR-612 suppresses
the stemness of liver cancer via Wnt/β-catenin signaling. Biochem
Biophys Res Commun. 447:210–215. 2014. View Article : Google Scholar : PubMed/NCBI
|
